SPECTRAL AI, INC. (MDAI) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 19.87M USD | Liabilities, Current |
| Cash and equivalents | 14.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.18M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 815.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $19.87M | $14.00M | (m) | $1.18M | $815.00K | (m) |
| 2026-03-31 | (m) | $21.27M | $11.70M | (m) | $1.19M | $831.00K | (m) |
| 2025-12-31 | (m) | $20.63M | $15.40M | (m) | $1.27M | $838.00K | (m) |
| 2025-09-30 | (m) | $15.77M | $10.50M | (m) | $990.00K | $454.00K | (m) |
| 2025-06-30 | (m) | $16.19M | $10.50M | (m) | $1.47M | $462.00K | (m) |
| 2025-03-31 | (m) | $13.31M | $14.10M | (m) | $2.10M | $437.00K | (m) |
| 2024-12-31 | (m) | $17.64M | $5.20M | (m) | $2.50M | $425.00K | (m) |
| 2024-09-30 | (m) | $13.07M | $3.70M | (m) | $2.83M | $443.00K | (m) |
| 2024-06-30 | (m) | $16.13M | $6.88M | (m) | $2.29M | $267.00K | (m) |
| 2024-03-31 | (m) | $17.51M | $10.16M | (m) | $1.83M | $228.00K | (m) |
| 2023-12-31 | (m) | $12.40M | $4.79M | (m) | $2.35M | $230.00K | (m) |
| 2023-09-30 | (m) | $10.65M | (m) | (m) | $1.31M | $220.00K | (m) |
| 2023-06-30 | (m) | $5.28M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.97M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $3.62M | $785.04K | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $3.34M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $3.02M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $3.03M | $465.92K | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.94M | $769.43K | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.33M | $863.77K | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $243.76K | $868.69K | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $369.49K | $1.62M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $140.57K | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |